[1] BAUDON E, PEYRE M, PEIRIS M, et al. Epidemiological features of influenza circulation in swine populations:A systematic review and meta-analysis[J]. PLoS One, 2017, 12(6):e0179044.
[2] PENSAERT M, OTTIS K, VANDEPUTTE J, et al. Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man[J]. Bull World Health Organ, 1981, 59(1):75-78.
[3] LIU J H, BI Y H, QIN K, et al. Emergence of European avian influenza virus-like H1N1 swine influenza A viruses in China[J]. J Clin Microbiol, 2009, 47(8):2643-2646.
[4] VINCENT A, AWADA L, BROWN I, et al. Review of influenza A virus in swine worldwide:A call for increased surveillance and research[J]. Zoonoses Public Health, 2014, 61(1):4-17.
[5] YANG H L, QIAO C L, TANG X, et al. Human infection from avian-like influenza A (H1N1) viruses in pigs, China[J]. Emerg Infect Dis, 2012, 18(7):1144-1146.
[6] ROVIDA F, PIRALLA A, MARZANI F C, et al. Swine influenza A (H1N1) virus (SIV) infection requiring extracorporeal life support in an immunocompetent adult patient with indirect exposure to pigs, Italy, October 2016[J]. Euro Surveill, 2017, 22(5):30456.
[7] YANG H L, CHEN Y, QIAO C L, et al. Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses[J]. Proc Natl Acad Sci U S A, 2016, 113(2):392-397.
[8] BYRD-LEOTIS L, CUMMINGS R D, STEINHAUER D A. The interplay between the host receptor and influenza virus hemagglutinin and neuraminidase[J]. Int J Mol Sci, 2017, 18(7):1541.
[9] SHVARTSMAN D E, KOTLER M, TALL R D, et al. Differently anchored influenza hemagglutinin mutants display distinct interaction dynamics with mutual rafts[J]. J Cell Biol, 2003, 163(4):879-888.
[10] SKEHEL J J, WILEY D C. Receptor binding and membrane fusion in virus entry:The influenza hemagglutinin[J]. Annu Rev Biochem, 2000, 69:531-569.
[11] CHEN Y X, QIN K, WU W L, et al. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes[J]. J Infect Dis, 2009, 199(1):49-58.
[12] NAUNDORF S, PREITHNER S, MAYER P, et al. In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment[J]. Int J Cancer, 2002, 100(1):101-110.
[13] BHAT S, BHATIA S, SOOD R, et al. Production and characterization of monoclonal antibodies against nucleoprotein of avian influenza virus[J]. Monoclon Antib Immunodiagn Immunother, 2013, 32(6):413-418.
[14] CHEN L M, RIVAILLER P, HOSSAIN J, et al. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States[J]. Virology, 2011, 412(2):401-410.
[15] OKUNO Y, ISEGAWA Y, SASAO F, et al. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains[J]. J Virol, 1993, 67(5):2552-2558.
[16] EKIERT D C, WILSON I A. Broadly neutralizing antibodies against influenza virus and prospects for universal therapies[J]. Curr Opin Virol, 2012, 2(2):134-141. |